Remote Monitoring and Teledentistry App In Hand Dental Partners With Five Star Orthodontic Laboratory & Supply, Inc.
Five Star Orthodontic Laboratory & Supply, Inc. has been servicing the Orthodontic community for over 30 years. They will be using the In Hand Dental platform to add strategic value to their Tri-Aligners product line a…
Transform the Little Voice Inside Into a Powerful Roar: Dr. Esther Zeledón’s ‘Creating Your Limitless Life’ to Be Released on September 15, 2023

\”Creating Your Limitless Life\” Dr Esther Zeledon
\”Creating Your Limitless Life\” by Dr Esther Zeledon
MIAMI, July 17, 2023 (Newswire.com)
–
After migrating to the United States from Nicaragua as a young child, Esther Zeledón was destined to chase the American Dream. As a high achiever from an immigrant neighborhood, she ticked off each of the boxes on her checklist; graduated top of her class, received a scholarship to a prestigious college, completed a Ph.D. from UC Berkeley, had a career as a diplomat, and started a family. Everything suggested that her struggles had paid off and she had made it. Yet, she knew something was missing- alignment.
That was when she became limitless.
Find out how Dr Esther Zeledón went from burn-out to embracing the boundless life she now leads when Dean Publishing releases “Creating Your Limitless Life” this Hispanic Heritage Month on September 15, 2023 (9/15/23). Designed with the high achiever in mind, this inspiring book is a guide to awakening the extraordinary possibilities that await inside everybody no matter who they are or where they come from. With Esther’s incredible story and her three-step approach, “Creating Your Limitless Life” is a roadmap to living an authentic life full of joy.
“I wrote this book because I’ve seen so many people, myself included, get trapped in these societal molds that crush our spirits and leave us feeling anxious, depressed, and without clarity about who we are or what we want,” says Esther. “Even worse, we perpetuate the cycle by passing those same pressures on to others. We don’t stop to listen to what others really want or need, causing us to question ourselves and place our purpose and true legacy on the back burner. My life’s purpose is to unlock the full potential of individuals as they uncover, pursue, and financially support their missions, visions, and purposes. I want them to embrace their inner voice rather than fear it.”
Synopsis
“Creating Your Limitless Life” presents a transformative three-step approach, empowering high achievers to transcend societal expectations and navigate the challenges of balancing ambition with personal fulfillment. Drawing from Dr. Esther Zeledón’s experiences as an immigrant, entrepreneur, and diplomat, this book challenges conventional norms, highlighting the significance of active self-listening. Through practical tools and real-life case studies, readers are guided to listen and not fear their inner voice so they can uncover their purpose, craft a personalized roadmap, and cultivate resilience. Going beyond traditional self-help, this book equips individuals with the necessary resources to achieve clarity on their next steps, unlock their boundless potential and embrace a truly fulfilling life.
To pre-order “Creating Your Limitless Life” visit https://beactchange.com/creating-your-limitless-life-book
For media inquiries or to schedule an interview with Esther Zeledon, please contact enquiries @pricelessmedia.com.au
Contact Information:
Nicki Price
Managing Director/Publicist
Original Source:
Transform the Little Voice Inside Into a Powerful Roar: Dr. Esther Zeledón’s ‘Creating Your Limitless Life’ to Be Released on September 15, 2023
The post Transform the Little Voice Inside Into a Powerful Roar: Dr. Esther Zeledón’s ‘Creating Your Limitless Life’ to Be Released on September 15, 2023 first appeared on RSVTV news.
VALO Holdings Group and CEO Jana Seaman Empower Habitat for Humanity Collier County Florida Through Team Volunteer Efforts

VALO Holdings Group, led by CEO Jana Seaman, bring their team to sponsor and participate in a community event with Habitat for Humanity of Collier County — working on a new construction to benefit families in need.
…
The post VALO Holdings Group and CEO Jana Seaman Empower Habitat for Humanity Collier County Florida Through Team Volunteer Efforts first appeared on RSVTV news.
GOBEL Receives Second Patent for Gratitude to Give
ST. PETERSBURG, Fla., July 14, 2023 (Newswire.com)
–
GOBEL, the world’s leading consulting and technology firm working exclusively for healthcare philanthropy…
POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

EuCorVac-19
EuCorVac-19, a recombinant protein vaccine displaying the SARS-CoV-2 receptor-binding domain (RBD) antigen on the immunogenic liposomes
BUFFALO, N.Y., July 14, 2023 (Newswire.com)
–
POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top line interim results of a Phase 3 clinical trial of EuCorVac-19, a COVID-19 vaccine candidate being developed by South Korean partner EuBiologics (KOSDAQ: 206650). EuCorVac-19 is a protein-based vaccine consisting of a vaccine antigen displayed on immunogenic nanoparticles, using POP BIO’s spontaneous-nanoliposome antigen particle (SNAP) technology.
The phase 3 trial of EuCorVac-19 was conducted in the Philippines in approximately 2,600 adults (NCT05572879). EuCorVac-19 demonstrated superior antibody immunogenicity compared to a World Health Organization Emergency Use Authorized adenoviral vector vaccine, thereby meeting the primary endpoint of the phase 3 trial.
The formation of neutralizing antibodies, which prevent COVID-19 infection, was more than twice as high in EuCorVac-19 compared to the control vaccine. EuCorVac-19 exhibited a high serological response rate with neutralizing antibody titers increasing after vaccination. In particular, the neutralizing antibody titers and serum response rates in subjects aged over 65 exceeded those of the control vaccine. In immunogenicity analysis against the Omicron BA.5 strain, EuCorVac-19 induced more than twice the neutralizing antibody titer compared to the control vaccine.
EuCorVac-19’s safety profile was further established in this phase 3 study. EuCorVac-19 showed a slightly lower incidence than the control vaccine of solicited adverse events and there was no difference between EuCorVac-19 and the control vaccine in the incidence of unsolicited adverse events.
These results further validate the strength and synergy of POP BIO’s SNAP and EuBiologics’ EuIMT platform technologies used in the EuCorVac-19 vaccine. Further development of booster vaccines, new strain vaccines, and combination vaccines for COVID-19 will be significantly more straightforward in the future.
“Achieving the completion of this Phase III trial is an enormous milestone for our technologies. These results provide validation towards not only solving this unprecedented global crisis but also provides invaluable support towards our platform’s development, further enabling the creation of new vaccines with tremendous potential to alleviate suffering worldwide,” said POP BIO co-founder Jonathan Smyth.
EuCorVac-19 was already shown to be safe and immunogenic in a Phase I/II clinical trial, the results of which were announced in December 2021. The Philippine Phase 3 trial, conducted since third quarter of 2022, were supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the ministry of Health & Welfare, Republic of Korea.
Based on the results of this clinical study, EuBiologics plans to apply for product approval in the Philippines shortly. Later this year, results will become available from a second independent Phase 3 clinical study being carried out in the Democratic Republic of Congo.
About POP Biotechnologies: POP Biotechnologies, Inc. is a privately held biotechnology company focused on the research and development of novel therapeutics and vaccines employing their proprietary porphyrin-phospholipid (PoP) liposome technologies. The PoP technology, exclusively licensed from the State University of New York Research Foundation (SUNY-RF), was developed by company co-founder Dr. Jonathan Lovell at his academic facilities at The State University of New York at Buffalo (SUNY Buffalo). POP Biotechnologies is currently a resident of the SUNY Buffalo incubator at Baird Research Park.
About POP BIO’s SNAP Technology: POP BIO’s Spontaneous Nanoliposome Antigen Particleization (SNAP) technology enables the rapid development and manufacturing of highly immunogenic particle-based vaccines and immunotherapies directed against infectious disease and cancer through the use of a cobalt modified variant of the PoP technology (CoPoP). The SNAP technology enables the seamless generation of stable particle-formation and liposome-display of protein and peptide antigens resulting in substantial improvements in immune responses.
About EuBiologics: EuBiologics is a South Korean Biotechnology company that is advancing the EuCorVac-19 COVID-19 vaccine and other vaccine products. EuBiologics has two main animal-based bioreactors (1,000L) to produce recombinant protein antigens at Chuncheon Plant 1(C-Plant) and EcML(Monophosphoryl Lipid A) which is adjuvant at Chuncheon Plant 2(V-Plant). The total capacity of the COVID-19 vaccine is currently in the hundreds of millions of doses per year.
About EuBiologics’ EuIMT Technology: EuBioloigcs’ Immune Modulation Technology using genetically engineered Monophosphoryl Lipid A (MLA), called EcML that is a unique TLR4 agonist. EuBiologics has IP protection around EcML and various adjuvant systems including EcML. Eubiologics’ EcML and POP BIO’s SNAP technologies synergize to create ultrapotent next-generation vaccines.
Contact Information:
Jonathan Smyth
President
+13152200087
Original Source:
POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
SupportDDS Welcomes Chief Growth Officer, RCM Solutions, Victoria Johnson
Victoria Headshot Chief Growth Officer-RCM Solutions of SupportDDS
ARGYLE, Texas, July 14, 2023 (Newswire.com)
–
SupportDDS is pleased to announce the…
Whittier Street Health Center’s 24th Annual Men’s Health Summit a Triumph

Men’s Health Honorees
William Watkins, Rev. John Finley, David Morales, Leverett Wing, Frederica M Williams, Jean Prezeau
BOSTON, July 14, 2023 (Newswire.com)
–
Whittier Street Health Center, a community health center with a mission to serve as a center of excellence that provides high quality and accessible health care and social services that achieve health equity, social justice, and the economic well-being of a diverse patient population, is thrilled to announce that its 24th Annual Men’s Health Summit held June 24 at the Frederica M. Williams Building, 1290 Tremont Street, Roxbury, was a tremendous success with an estimated 150 community leaders and residents in attendance.
The theme at this year’s summit, “UNITED for Men’s Health: Grounded in Equity,” prompted open and engaging discussion on how, across the country, gaps and disparities in health care continue to increase and persist.
The annual event included a health fair, health screenings, and a panel discussion and conversation about men’s health and wellness. A highlight of the Summit was the presentation of this year’s Men’s Health Champion Awards to the following:
- Mr. Wilner Auguste, founder, Haitian American United (HAU), Mattapan;
- Rev. John Finley, co-founder and head of Epiphany School, Dorchester;
- Rev. Art Gordon, pastor, St. John Missionary Baptist Church, Roxbury;
- Mr. David Morales, general manager, UniCare, Lynn (formerly of Lynnfield);
- Mr. Jean Prezeau, men’s health ambassador, Whitter Street Health Center, Roxbury;
- Mr. William Watkins, MBA, vice president of digital strategies and partnerships, Urban League of Eastern Massachusetts, Roxbury; and
- Mr. Leverett Wing, president and CEO, Commonwealth Seminar, Chelsea and Boston.
Serving as guest speaker was NBC10 News Anchor Glenn Jones.
The Annual Men’s Health Summit aligns with Whittier Street Health Center’s mission to serve as a center of excellence that provides high-quality, and accessible health care and social services that achieve health equity, social justice, and the economic well-being of our diverse populations.
“Open, honest, and genuine discussions were once again a high point of this year’s Men’s Health Summit,” said Frederica M. Williams, president and CEO of Whittier Street Health Center. “This important annual event aims to shine a light on and help to address preventable causes that contribute to increased morbidity and mortality rates, and decreased life expectancy for men, and in particular those of color.”
About Whittier Street Health Center
Whittier Street Health Center is an independently licensed community health care center with a mission of providing high-quality, reliable and accessible primary healthcare for diverse populations while promoting wellness and eliminating health and social disparities. A champion of equitable access to high-quality, patient-focused care, social justice and economic equity, Whittier Street Health Center serves more than 30,000 patients and 20,000 community outreach visits annually; its ethnically and racially diverse patient base is primarily made up of individuals from Roxbury, Dorchester, Jamaica Plain, the South End and greater Boston. For more information, please visit www.wshc.org as well as Facebook (www.facebook.com/WhittierStreetHealthCenter), Twitter (@Whittier_Boston), or LinkedIn (https://www.linkedin.com/company/whittier-street-health-center), or call 617-989-3221.
Contact Information:
Nicole Hales
President, PRfirst
617-947-7983
Frederica Williams
President & CEO
617-989-3221
Original Source:
Whittier Street Health Center’s 24th Annual Men’s Health Summit a Triumph
The Men at Shoreline Recovery Center and Park Mental Health Learn Self-Care Techniques to Sustain Them Along Their Addiction Recovery Journey
SAN DIEGO, July 14, 2023 (Newswire.com)
–
Taking care of one’s physical well-being is essential on the road to addiction recovery. For the men at Shorel…
ApolloMD Announces Winner of 2023 Emergency Medicine Scholarship for Residents
ATLANTA, July 14, 2023 (Newswire.com)
–
Bilal Shaukat, DO, a second-year emergency medicine resident in Brooklyn is the 2023 winner of the 6th Annual Ap…
Curated Mental Health Emphasizes the Importance of Professional Support in Psychedelic Therapy for Optimal Mental Health Outcomes
NEW YORK, July 14, 2023 (Newswire.com)
–
Is ketamine a powerful tool for therapeutic purposes? Absolutely. But are there risks associated with its misuse? The…
